Industry Symposium: Evolving treatment paradigm in HER2+ early breast cancer
Supported by Daiichi-Sankyo | AstraZeneca
Friday, October 09, 2026 | Hall B (Great Hall 2)
11:30-12:30
Admission to this symposium is included as part of the congress registration
| Chairperson: | Bruce Mann, Melbourne, Australia |
| Faculty: | Steven David, Melbourne, Australia |